Showing results (211-220 of 288) with videos related to
Sort By:
Pageof 29
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 4, 2024
Inadequate management of opioid-induced constipation in European cancer pain patients: results of a real-world, multicentre, observational study ("E-StOIC")Andrew Davies, Norah Fagan, Jesus Gonzalez-Barboteo, et al.Haematologica|December 22, 2018
Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progressionJohn F Seymour, Robert Marcus, Andrew Davies, et al.The New England Journal of Medicine|October 23, 2018
Energy-Dense versus Routine Enteral Nutrition in the Critically Ill, Marianne Chapman, Sandra L Peake, et al.British Journal of Haematology|April 26, 2013
Use of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization: an analysis of mobilization and engraftmentAmy Publicover, Deborah S Richardson, Andrew Davies, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 24, 2024
Opioid analgesic dose and route conversion ratio studies: a scoping review to inform an eDelphi guidelineMellar P Davis, Andrew Davies, Mary Lynn McPherson, et al.Critical Care and Resuscitation : Journal of the Australasian Academy of Critical Care Medicine|September 12, 2012
End points for phase II trials in intensive care: recommendations from the Australian and New Zealand Clinical Trials Group consensus panel meetingPaul Young, Carol Hodgson, Joel Dulhunty, et al.Annals of Hematology|April 22, 2020
Health-related quality of life in the phase III GALLIUM study of obinutuzumab- or rituximab-based chemotherapy in patients with previously untreated advanced follicular lymphomaAndrew Davies, Peter Trask, Judit Demeter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 20, 2014
Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I studyMichelle A Fanale, Steven M Horwitz, Andres Forero-Torres, et al.Pharmaceutical Research|July 27, 2023
Single-dose pharmacokinetics and lung function of nebulized niclosamide ethanolamine in sheepAnne Weiss, Robert J Bischof, Cornelia B Landersdorfer, et al.Scientific Reports|March 2, 2016
Strain-Engineered Graphene Grown on Hexagonal Boron Nitride by Molecular Beam EpitaxyAlex Summerfield, Andrew Davies, Tin S Cheng, et al.Pageof 29